Aurobindo Pharma Arm to Market Biosimilar to Treat Crohn’s Disease, Arthritis
Aurobindo Pharma has proclaimed that its wholly owned subsidiary CuraTeQ Biologics has got into a special licence deal with the US-based BioFactura for biosimilar product...